Products in the medicated skin care market to reach value of $6.2 billion

Products within the global medicated skin care market are forecast to reach a value of US $6.2 billion by the year 2017. Product growth within the medicated skin care market is set to be primarily driven by the world's aging population and the insistent pursuit of achieving youthful looks and flawless skin.

Furthermore, innovation, product expansion, and celebrity endorsement are set to pep up the ever young appeal of the market, together with a host of new product launches.

While acne bogs down teenagers, premature aging bothers the twenty-some things. Four-fifths of the world's teen population is victim to acne and is relying heavily on medicated creams that cleanse the skin blemish-free from acne and prevent recurrence, spelling untold opportunity for products within the medicated skin care market.

With concerns for effective skincare mounting, the US remains the most active market for skincare products, irrespective of the category the US represents the largest regional for products within the medicated skin care market worldwide. Anti-aging skincare products lead the pack, both by volumes and growth impetus, powered by the spending arsenal of baby boomers, quickly ageing now.

Asia-Pacific with its huge population base, rising disposable incomes and evolving markets of India, China, Australia, Malaysia and Thailand among others, offers tremendous untapped market potential. The Asian market is set to forge ahead at a CAGR of approximately 6% through to 2017.

For more information on products within the medicated skin care market, see the latest research: Medicated Skin Care Market Report

Follow us on Twitter @CandMResearch